Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome.
Jung Beom SeoYeon Kyung ChoiHye In WooYun A JungSungwoo LeeSeunghyeong LeeMihyang ParkIn Kyu LeeGwon Soo JungKeun Gyu ParkPublished in: Diabetes & metabolism journal (2019)
The present study shows that activation of the NLRP3 inflammasome contributes to UUO-induced renal fibrosis and the renoprotective effect of gemigliptin is associated with attenuation of NLRP3 inflammasome activation.